Nokhbegan Pharmaceutical Investment
Company (Nophico)
Nokhbegan Pharmaceutical Investment
Company (Nophico) stands as one of Iran's largest and most successful
pharmaceutical conglomerates, specializing in various sectors and boasting a
legacy of over 60 years of activity. Our expansive presence encompasses all
facets of the pharmaceutical realm, offering a comprehensive array of
medicines.
At the core of Nophico
Pharmaceutical Holding is our paramount mission: to provide and produce
high-quality products adhering to the most stringent standards and employing
the latest performance methodologies in accordance with international laws and
regulations. Additionally, our commitment to continuous adaptation and
forward-thinking positions Nophico as an elite holding.
With a visionary approach geared
towards creating innovative spaces, this holding is dedicated to enhancing the
industry's standing and related sectors. Nophico endeavors to revolutionize and
advance the supply of medicine, fostering a transformative impact.
Our adherence to primary approvals,
Good Manufacturing Practice (GMP), and an integrated management system empowers
us to seamlessly achieve our shared goals and objectives.
Holding subsidiary companies:
Tehran darou pharmaceutical company
Tehran chemie pharmaceutical
company www.Tehranchemie.com
Afa chemi pharmaceutical
company www.afachemi.com
Iran hormon pharmaceutical
company www.iranhormone.com
Vana darougostar www.vdgco.ir